GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Microbix Biosystems Inc (TSX:MBX) » Definitions » EV-to-FCF

Microbix Biosystems (TSX:MBX) EV-to-FCF : 1,060.62 (As of May. 09, 2024)


View and export this data going back to 1992. Start your Free Trial

What is Microbix Biosystems EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Microbix Biosystems's Enterprise Value is C$39.24 Mil. Microbix Biosystems's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was C$0.04 Mil. Therefore, Microbix Biosystems's EV-to-FCF for today is 1,060.62.

The historical rank and industry rank for Microbix Biosystems's EV-to-FCF or its related term are showing as below:

TSX:MBX' s EV-to-FCF Range Over the Past 10 Years
Min: -235.6   Med: -13.13   Max: 1434.07
Current: 1079.19

During the past 13 years, the highest EV-to-FCF of Microbix Biosystems was 1434.07. The lowest was -235.60. And the median was -13.13.

TSX:MBX's EV-to-FCF is ranked worse than
98.69% of 381 companies
in the Biotechnology industry
Industry Median: 6.23 vs TSX:MBX: 1079.19

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-09), Microbix Biosystems's stock price is C$0.33. Microbix Biosystems's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was C$0.027. Therefore, Microbix Biosystems's PE Ratio for today is 12.22.


Microbix Biosystems EV-to-FCF Historical Data

The historical data trend for Microbix Biosystems's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Microbix Biosystems EV-to-FCF Chart

Microbix Biosystems Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only -64.05 -42.69 96.23 43.93 -17.42

Microbix Biosystems Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 48.80 -44.30 -29.23 -17.42 1,274.31

Competitive Comparison of Microbix Biosystems's EV-to-FCF

For the Biotechnology subindustry, Microbix Biosystems's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Microbix Biosystems's EV-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Microbix Biosystems's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Microbix Biosystems's EV-to-FCF falls into.



Microbix Biosystems EV-to-FCF Calculation

Microbix Biosystems's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=39.243/0.037
=1,060.62

Microbix Biosystems's current Enterprise Value is C$39.24 Mil.
Microbix Biosystems's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.04 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Microbix Biosystems  (TSX:MBX) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Microbix Biosystems's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.33/0.027
=12.22

Microbix Biosystems's share price for today is C$0.33.
Microbix Biosystems's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.027.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Microbix Biosystems EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Microbix Biosystems's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Microbix Biosystems (TSX:MBX) Business Description

Traded in Other Exchanges
Address
265 Watline Avenue, Mississauga, ON, CAN, L4Z 1P3
Microbix Biosystems Inc develops biological products and technologies. The company manufactures and develops cell culture-based biological products and technologies. It has developed and acquired two technologies; Kinlytic and LumiSort. The company's operating segment includes Antigen, QAPs DxTM and Other Includes Kinlytic. It generates maximum revenue from the Antigen QAPs segment. Geographically, it derives a majority of revenue from North America.
Executives
James Stuart Currie Senior Officer

Microbix Biosystems (TSX:MBX) Headlines

No Headlines